BRPI0813670A2 - Compostos para tratamento - Google Patents

Compostos para tratamento

Info

Publication number
BRPI0813670A2
BRPI0813670A2 BRPI0813670-0A2A BRPI0813670A BRPI0813670A2 BR PI0813670 A2 BRPI0813670 A2 BR PI0813670A2 BR PI0813670 A BRPI0813670 A BR PI0813670A BR PI0813670 A2 BRPI0813670 A2 BR PI0813670A2
Authority
BR
Brazil
Prior art keywords
treatment compounds
compounds
treatment
Prior art date
Application number
BRPI0813670-0A2A
Other languages
English (en)
Portuguese (pt)
Inventor
Claude Michel Wischik
Roger Todd Staff
Gernot Riedel
Elizabeth Anne Goatman
Dominic Venay Harbaran
Serena Deiana
Damon Jude Wischik
Alison Dorothy Murray
Original Assignee
Wista Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wista Lab Ltd filed Critical Wista Lab Ltd
Publication of BRPI0813670A2 publication Critical patent/BRPI0813670A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0813670-0A2A 2007-06-19 2008-06-17 Compostos para tratamento BRPI0813670A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94500607P 2007-06-19 2007-06-19
PCT/GB2008/002066 WO2008155533A2 (en) 2007-06-19 2008-06-17 Phenothiazine compounds for treating mild cognitive impairment

Publications (1)

Publication Number Publication Date
BRPI0813670A2 true BRPI0813670A2 (pt) 2014-12-30

Family

ID=39943003

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813670-0A2A BRPI0813670A2 (pt) 2007-06-19 2008-06-17 Compostos para tratamento

Country Status (16)

Country Link
US (1) US9211294B2 (cg-RX-API-DMAC7.html)
EP (1) EP2167095B1 (cg-RX-API-DMAC7.html)
JP (1) JP5725605B2 (cg-RX-API-DMAC7.html)
CN (1) CN101820884B (cg-RX-API-DMAC7.html)
AU (1) AU2008265045B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0813670A2 (cg-RX-API-DMAC7.html)
CA (1) CA2690746C (cg-RX-API-DMAC7.html)
DK (1) DK2167095T3 (cg-RX-API-DMAC7.html)
ES (1) ES2739546T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191513T1 (cg-RX-API-DMAC7.html)
HU (1) HUE045460T2 (cg-RX-API-DMAC7.html)
MY (1) MY177001A (cg-RX-API-DMAC7.html)
PL (1) PL2167095T3 (cg-RX-API-DMAC7.html)
PT (1) PT2167095T (cg-RX-API-DMAC7.html)
SI (1) SI2167095T1 (cg-RX-API-DMAC7.html)
WO (1) WO2008155533A2 (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109384741B (zh) 2006-03-29 2023-01-06 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物盐及其用途
PL2205245T3 (pl) * 2007-10-03 2015-12-31 Wista Lab Ltd Zastosowanie terapeutyczne diaminofenotiazyn
US8828986B2 (en) 2011-04-20 2014-09-09 Prosetta Antiviral Inc. Antiviral compounds
JP5868955B2 (ja) 2010-04-30 2016-02-24 プロセッタ アンチバイラル インコーポレイテッド 抗ウイルス化合物
AU2011358840B2 (en) * 2011-02-11 2017-05-04 TauRx Therapeutics Management Ltd Phenothiazine diaminium salts and their use
PL3470390T3 (pl) * 2013-01-30 2023-11-06 Ecolab Usa Inc. Zmiatacze siarkowodoru
US10304006B2 (en) * 2013-02-15 2019-05-28 The Charles Stark Draper Laboratory, Inc. Method for integrating and fusing heterogeneous data types to perform predictive analysis
WO2016133995A1 (en) * 2015-02-17 2016-08-25 Arizona Board Of Regents On Behalf Of Arizona State University Phenothiazine analogues as mitochondrial therapeutic agents
EP4223297A3 (en) * 2016-07-25 2023-11-15 WisTa Laboratories Ltd. Administration and dosage of diaminophenothiazines
GB201614834D0 (en) * 2016-09-01 2016-10-19 Wista Lab Ltd Treatment of dementia
FI3826639T3 (fi) * 2018-07-26 2024-10-30 Wista Lab Ltd Diaminofenotiatsiinien optimoitu annostus populaatioille
MY209608A (en) * 2019-04-10 2025-07-24 Genting Taurx Diagnostic Centre Sdn Bhd Adaptive neurological testing method
GB201909454D0 (en) 2019-07-01 2019-08-14 Wista Lab Ltd Enhancers
GB201909493D0 (en) 2019-07-01 2019-08-14 Wista Lab Ltd Therapeutic interactions
GB201909506D0 (en) 2019-07-02 2019-08-14 Wista Lab Ltd Synaptopathies
CA3257856A1 (en) 2022-05-31 2023-12-07 Wista Laboratories Ltd. TREATMENT OF NEURODEGENERATIVE DISORDERS USING COMPOUNDS CONTAINING METHYLTHIONINIUM (MT)
AU2024231880A1 (en) 2023-03-03 2025-09-11 Taurx Therapeutics Management Ltd. Diaminophenothiazine for the treatment of microvascular brain disease disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9506197D0 (en) * 1995-03-27 1995-05-17 Hoffmann La Roche Inhibition of tau-tau association.
GB0017060D0 (en) * 2000-07-11 2000-08-30 Hunter Fleming Ltd Production, stabilisation and use of reduced forms of pharmaceutical compounds
GB0101049D0 (en) * 2001-01-15 2001-02-28 Univ Aberdeen Materials and methods relating to protein aggregation in neurodegenerative disease
WO2004087160A1 (en) * 2003-04-03 2004-10-14 Prana Biotechnology Ltd Treatment of neurological conditions
PT1799662E (pt) * 2004-09-23 2013-07-09 Wista Lab Ltd Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc)
CN101084204B (zh) * 2004-09-23 2012-12-05 卫思道制药有限公司 包括亚甲蓝(mtc)在内的二氨基吩噻嗪鎓化合物的化学合成和纯化方法
WO2006091728A2 (en) * 2005-02-24 2006-08-31 The Trustees Of The University Of Pennsylvania Microtubule stabilizing compounds and methods of their use
EP2001556B1 (en) * 2006-03-29 2014-10-01 Wista Laboratories Ltd. Thioninium compounds and their use
CN101460157B (zh) * 2006-03-29 2015-09-02 维斯塔实验室有限公司 蛋白聚集抑制剂
CN109384741B (zh) * 2006-03-29 2023-01-06 维斯塔实验室有限公司 3,7-二氨基-10h-吩噻嗪化合物盐及其用途
DK2457904T3 (en) 2006-07-11 2015-01-12 Wista Lab Ltd Methods for the synthesis and / or purification of the compounds diaminophenothiazinium

Also Published As

Publication number Publication date
CN101820884A (zh) 2010-09-01
SI2167095T1 (sl) 2019-09-30
WO2008155533A3 (en) 2009-02-19
MY177001A (en) 2020-09-01
JP5725605B2 (ja) 2015-05-27
PT2167095T (pt) 2019-08-06
EP2167095B1 (en) 2019-05-29
AU2008265045B2 (en) 2014-02-27
HUE045460T2 (hu) 2019-12-30
DK2167095T3 (da) 2019-07-29
PL2167095T3 (pl) 2019-11-29
US20100184752A1 (en) 2010-07-22
CN101820884B (zh) 2013-08-28
WO2008155533A2 (en) 2008-12-24
EP2167095A2 (en) 2010-03-31
CA2690746A1 (en) 2008-12-24
AU2008265045A1 (en) 2008-12-24
JP2010530403A (ja) 2010-09-09
CA2690746C (en) 2018-01-02
ES2739546T3 (es) 2020-01-31
HRP20191513T1 (hr) 2019-11-29
US9211294B2 (en) 2015-12-15

Similar Documents

Publication Publication Date Title
BRPI0813670A2 (pt) Compostos para tratamento
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
ATE502948T1 (de) Substituierte bicyclolactamverbindungen
BRPI0815042A2 (pt) Compostos de pirazol
EP2131749A4 (en) Surgical stapling apparatus
BRPI0910282A2 (pt) Composto oxadiazo-antraceno para o tratamento de diabetes
DK2175851T3 (da) Biofilmbehandling
BRPI0811264A2 (pt) Compostos
BRPI0809996A2 (pt) Compostos
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0922884A2 (pt) compostos para tratamento de câncer
DK2173831T3 (da) Brøndbehandling
DK2235041T3 (da) Antimikrobielle forbindelser
BRPI0815181A2 (pt) Compostos
BRPI0820410A2 (pt) Lactans substituídos terapêuticos
BRPI0818598A2 (pt) agentes terapêuticos - 802
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0814613A2 (pt) Compostos
PL3825306T3 (pl) Związki morfinanu
BRPI0918508A2 (pt) orto-aminoanilidas para o tratamento de câncer
BRPI0922216A2 (pt) tratamento para glomerulonefrite
BRPI0909764A2 (pt) compostos terapêuticos
BRPI0812105A2 (pt) Neramexano para o tratamento de nistagmo
BRPI0906879A2 (pt) Compostos terapêuticos

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: WISTA LABORATORIES LTD. (SG)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL